Current Outcome of Patients With Ureteral Stents for the Management of Malignant Ureteral Obstruction

Abstract

Gynecologic cancer was a significant favorable predictor of stent failure-free survival. Patients treated with an indwelling retrograde ureteral stent for malignant ureteral obstruction were divided into 3 groups, which showed significant differences in overall survival. This risk classification may help urologists predict survival time.